Transjugular Intrahepatic Portosystemic Shunt for Budd–Chiari Syndrome: A Single-Centre Experience.

Bibliographic Details
Title: Transjugular Intrahepatic Portosystemic Shunt for Budd–Chiari Syndrome: A Single-Centre Experience.
Authors: Joueidi, Faisal, Alhanaee, Amnah, Alsuhaibani, Hamad, Albenmousa, Ali, Joueidi, Ahmad, Elhassan, Ahmed, Nasir, Abdallah Nabeel, Marquez, Kris Ann Hervera, Alghamdi, Saad, Al Hamoudi, Waleed, Abualganam, Saad, Broering, Dieter, Bzeizi, Khalid Ibrahim
Source: Journal of Clinical Medicine; Oct2024, Vol. 13 Issue 19, p5858, 8p
Subject Terms: LIVER transplantation, SYMPTOMS, OVERALL survival, ABDOMINAL pain, SURVIVAL rate
Abstract: Background: Despite several challenges in clinical management, there has been significant progress in understanding the aetiology, natural history and outcomes of Budd–Chiari syndrome (BCS) treatments. This study aims to evaluate the outcomes of transjugular intrahepatic portosystemic shunt (TIPS) using covered stent in management of BCS. Methods: We conducted a retrospective analysis of 70 BCS patients who underwent TIPS using covered stents between January 2010 and December 2022 at a single tertiary liver transplant centre. Patients' clinical features, laboratory parameters, and imagine findings were collected before and after TIPS. The primary endpoint was overall survival. Results: TIPS was performed on 70 patients with BCS out of a total of 88 patients. The remaining patients (18) underwent liver transplantation. The mean age was 37.7 ± 11.2 years at time of diagnosis and the majority were female (64.35). The most common symptoms and signs at presentation were abdominal pain, jaundice, ascites, and variceal bleeding. Over a median followup of 76 months, the survival rates at 1, 3, and 5 years were 98.8%, 97.9%, and 97.7%, respectively. Patients who underwent TIPS alone had better survival that patients with BCS who required liver transplantation (LTx) (p = 0.003). Conclusions: In our study TIPS provided a highly effective treatment option for BCS patients. The long-term favourability of the outcome was not impacted by the need for repeated TIPS revision. Use of covered stents was instrumental in reducing shunt dysfunction rates. Prospective and larger studies are needed to further optimize therapeutic strategies in this challenging population. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Clinical Medicine is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:20770383
DOI:10.3390/jcm13195858
Published in:Journal of Clinical Medicine
Language:English